Abstract
Early identification of acute gout is crucial, enabling healthcare professionals to implement targeted interventions for rapid pain relief and preventing disease progression, ensuring improved long-term joint function. In this study, we comprehensively explored the potential of gout flare (GF) early detection based on nurse chief complaint notes in the Emergency Department (ED). Addressing the challenge of identifying GFs prospectively during an ED visit, where documentation is typically minimal, our research focuses on employing alternative Natural Language Processing (NLP) techniques to enhance the detection accuracy. We investigate GF detection algorithms using both sparse representations by traditional NLP methods and dense encodings by medical domain-specific Large Language Models (LLMs), distinguishing between generative and discriminative models. Three methods are used to alleviate the issue of severe data imbalance, including oversampling, class weights, and focal loss. Extensive empirical studies are done on the Gout Emergency Department Chief Complaint Corpora. Sparse text representations like tf-idf proved to produce strong performance, achieving higher than 0.75 F1 Score. The best deep learning models are RoBERTa-Large-PM-M3-Voc and BioGPT, with the best F1 Scores on each dataset with a 0.8 on the 2019 dataset and a 0.85 F1 Score the 2020 dataset. We concluded that although discriminative LLMs performed better for this classification task, compared to generative LLMs, a combination of using generative models as feature extractors and employing support vector machine for classification yields promising results comparable to those obtained with discriminative models.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
lopesoll{at}uni.coventry.ac.uk
xiaorui.jiang{at}coventry.ac.uk
nellippila{at}uni.coventry.ac.uk
karajagip{at}uni.coventry.ac.uk
removed publisher logo to avoid confusion, revised author contributions (removing equal contribution statement)
Data Availability Statement
The dataset the current paper used is a public dataset, which is available through PhysioNet at https://doi.org/10.13026/96v3-dw72.